ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Roche Picks New East Coast Hub

by Lisa M. Jarvis
October 1, 2012 | APPEARED IN VOLUME 90, ISSUE 40

Just months after announcing the closure of its Nutley, N.J., R&D labs, Roche says it is opening a Translational Clinical Research Center in New York City. The company says it considered other sites in New Jersey and New York, but chose lab space in the Alexandria Center for Life Sciences for its proximity to academic medical centers and other stakeholders. The translational center, with a staff of roughly 240, will represent a significantly smaller East Coast footprint than the Nutley site, the closure of which cost 1,000 people their jobs. The Alexandria center already houses Pfizer and ImClone, Eli Lilly & Co.’s oncology drug arm. Roche has signed an 11-year lease in the building.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment